(Q54354951)

English

Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

chronic myeloid leukemia

0 references

Michael Lauseker

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Andreas Hochhaus

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Stefan W. Krause

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

B Hanfstein

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

V Shlyakhto

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

R Hehlmann

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

S Saussele

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

C Dietz

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

P Erben

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

A Fabarius

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

U Proetel

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

S Schnittger

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

J Schubert

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

H Einsele

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

M Hänel

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

J Dengler

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

C Falge

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

L Kanz

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

A Neubauer

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

M Kneba

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

F Stegelmann

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

M Pfreundschuh

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

C F Waller

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

K Spiekermann

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

G M Baerlocher

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

M Pfirrmann

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

J Hasford

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

W-K Hofmann

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

M C Müller

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

SAKK and the German CML Study Group

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

publication date

6 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1988-1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24798484%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Resistance to targeted therapy in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Front-line and salvage therapies with tyrosine kinase inhibitors and other treatments in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Harmonization of molecular monitoring of CML therapy in Europe

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Standardisation of molecular monitoring for chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2014.153

21 January 2018

Prognostic discrimination in "good-risk" chronic granulocytic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24798484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of survival by tumor response.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24798484

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54354951&oldid=2212437311"